Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial (vol 180, pg 1345, 2020)

被引：0
|
作者：
Hermine, O.
Mariette, X.
Tharaux, P-L
Resche-Rigon, M.
Porcher, R.
Ravaud, p
机构：
来源：
JAMA INTERNAL MEDICINE | 2021年 / 181卷 / 07期
关键词：
D O I：
10.1001/jamainternmed.2021.3845
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1021 / 1021
页数：1
相关论文
共 50 条
  • [41] Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
    Bruen, Charles
    Al-Saadi, Mukhtar
    Michelson, Edward A.
    Tanios, Maged
    Mendoza-Ayala, Raul
    Miller, Joseph
    Zhang, Jeffrey
    Stauderman, Kenneth
    Hebbar, Sudarshan
    Hou, Peter C.
    CRITICAL CARE, 2022, 26 (01)
  • [42] Subcutaneous Sarilumab in Hospitalized Patients with Moderate-severe COVID-19 Infection Compared to the Standard Care: An Open-label Randomized Clinical Trial
    Rodriguez-Garcia, Sebastian C.
    Gonzalez-Alvaro, Isidoro
    Abad-Santos, Francisco
    Bautista-Hernandez, Azucena
    Garcia-Fraile, Lucio
    Pablo Baldivieso-Acha, Juan
    Sanz-Sanz, Jesus
    Garcia de Vicuna, Rosario
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 167 - 170
  • [43] Tocilizumab in combination with standard of care in patients with severe COVID-19 pneumonia: Efficacy and safety from a phase 3 clinical trial in Japan
    Mori, Nobuyoshi
    Nanki, Toshihiro
    Hirakawa, Akihiro
    Yamato, Masaya
    Kaneko, Yuko
    Shiokawa, Rie
    Ozaki, Ryoto
    Kawabata, Norihiro
    Ohmagari, Norio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
  • [44] Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial (vol 77, pg 261, 2020)
    Li, L.
    Zhang, W.
    Hu, Y.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (05): : 519 - 519
  • [45] Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial
    Menichetti, Francesco
    Popoli, Patrizia
    Puopolo, Maria
    Spila Alegiani, Stefania
    Tiseo, Giusy
    Bartoloni, Alessandro
    De Socio, Giuseppe Vittorio
    Luchi, Sauro
    Blanc, Pierluigi
    Puoti, Massimo
    Toschi, Elena
    Massari, Marco
    Palmisano, Lucia
    Marano, Giuseppe
    Chiamenti, Margherita
    Martinelli, Laura
    Franchi, Silvia
    Pallotto, Carlo
    Suardi, Lorenzo Roberto
    Luciani Pasqua, Barbara
    Merli, Marco
    Fabiani, Plinio
    Bertolucci, Luca
    Borchi, Beatrice
    Modica, Sara
    Moneta, Sara
    Marchetti, Giulia
    d'Arminio Monforte, Antonella
    Stoppini, Laura
    Ferracchiato, Nadia
    Piconi, Stefania
    Fabbri, Claudio
    Beccastrini, Enrico
    Saccardi, Riccardo
    Giacometti, Andrea
    Esperti, Sara
    Pierotti, Piera
    Bernini, Laura
    Bianco, Claudia
    Benedetti, Sara
    Lanzi, Alessandra
    Bonfanti, Paolo
    Sani, Spartaco
    Saracino, Annalisa
    Castagna, Antonella
    Trabace, Luigia
    Lanza, Maria
    Focosi, Daniele
    Mazzoni, Alessandro
    Pistello, Mauro
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [46] Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
    van den Berg, Karin
    Glatt, Tanya Nadia
    Vermeulen, Marion
    Little, Francesca
    Swanevelder, Ronel
    Barrett, Claire
    Court, Richard
    Bremer, Marise
    Nyoni, Cynthia
    Swarts, Avril
    Mmenu, Cordelia
    Crede, Thomas
    Kritzinger, Gerdien
    Naude, Jonathan
    Szymanski, Patryk
    Cowley, James
    Moyo-Gwete, Thandeka
    Moore, Penny L.
    Black, John
    Singh, Jaimendra
    Bhiman, Jinal N.
    Baijnath, Prinita
    Mody, Priyesh
    Malherbe, Jacques
    Potgieter, Samantha
    van Vuuren, Cloete
    Maasdorp, Shaun
    Wilkinson, Robert J.
    Louw, Vernon J.
    Wasserman, Sean
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
    Karin van den Berg
    Tanya Nadia Glatt
    Marion Vermeulen
    Francesca Little
    Ronel Swanevelder
    Claire Barrett
    Richard Court
    Marise Bremer
    Cynthia Nyoni
    Avril Swarts
    Cordelia Mmenu
    Thomas Crede
    Gerdien Kritzinger
    Jonathan Naude
    Patryk Szymanski
    James Cowley
    Thandeka Moyo-Gwete
    Penny L. Moore
    John Black
    Jaimendra Singh
    Jinal N. Bhiman
    Prinita Baijnath
    Priyesh Mody
    Jacques Malherbe
    Samantha Potgieter
    Cloete van Vuuren
    Shaun Maasdorp
    Robert J. Wilkinson
    Vernon J. Louw
    Sean Wasserman
    Scientific Reports, 12
  • [48] Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
    Matino, Erica
    Tavella, Elena
    Rizzi, Manuela
    Avanzi, Gian Carlo
    Azzolina, Danila
    Battaglia, Antonio
    Becco, Paolo
    Bellan, Mattia
    Bertinieri, Giovanni
    Bertoletti, Massimo
    Casciaro, Giuseppe Francesco
    Castello, Luigi Mario
    Colageo, Umberto
    Colangelo, Donato
    Comolli, Davide
    Costanzo, Martina
    Croce, Alessandro
    D'Onghia, Davide
    Della Corte, Francesco
    De Mitri, Luigi
    Dodaro, Valentina
    Givone, Filippo
    Gravina, Alessia
    Grillenzoni, Luca
    Gusmaroli, Graziano
    Landi, Raffaella
    Lingua, Anna
    Manzoni, Roberto
    Marinoni, Vito
    Masturzo, Bianca
    Minisini, Rosalba
    Morello, Marina
    Nelva, Anna
    Ortone, Elena
    Paolella, Rita
    Patti, Giuseppe
    Pedrinelli, Anita
    Pirisi, Mario
    Ravizzi, Lidia
    Rizzi, Eleonora
    Sola, Daniele
    Sola, Mariolina
    Tonello, Nadir
    Tonello, Stelvio
    Topazzo, Gigliola
    Tua, Aldo
    Valenti, Piera
    Vaschetto, Rosanna
    Vassia, Veronica
    Zecca, Erika
    NUTRIENTS, 2023, 15 (05)
  • [49] Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial
    Siami, Zeinab
    Aghajanian, Sepehr
    Mansouri, Somayeh
    Mokhames, Zakiye
    Pakzad, Reza
    Kabir, Kourosh
    Norouzi, Mehdi
    Soleimani, Alireza
    Yaghoobi, Mojtaba Hedayat
    Shadabi, Shahrzad
    Tajbakhsh, Ramin
    Kheirabad, Ali Kargar
    Mozhgani, Sayed-Hamidreza
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 : 306 - 308
  • [50] Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
    Chew, Kara W.
    Moser, Carlee
    Daar, Eric S.
    Wohl, David A.
    Li, Jonathan Z.
    Coombs, Robert W.
    Ritz, Justin
    Giganti, Mark
    Javan, Arzhang Cyrus
    Li, Yijia
    Choudhary, Manish C.
    Deo, Rinki
    Malvestutto, Carlos
    Klekotka, Paul
    Price, Karen
    Nirula, Ajay
    Fischer, William
    Bala, Veenu
    Ribeiro, Ruy M.
    Perelson, Alan S.
    Fletcher, Courtney, V
    Eron, Joseph J.
    Currier, Judith S.
    Hughes, Michael D.
    Smith, Davey M.
    NATURE COMMUNICATIONS, 2022, 13 (01)
12345